Over a million cases of Cutaneous Squamous Cell Carcinoma are diagnosed annually. For eligible patients, surgery has been the primary treatment modality in part due to high cure rates. Patients ineligible for surgery have often been left with a dismal set of options. New therapeutic modalities, however, are now changing the way clinicians’ approach cSCC, particularly for tumors unamenable to surgery. Join medical oncologists, dermatologists, and Mohs surgeons as they explore the safety and efficacy of emerging systemic therapies, including conversations with patients and caregivers.
4wholeness.com production team
Regina B. Butler RN-BC
Peter
LivDerm
European Hematology Association
Nikhil Yadav
Scientific Education Support
UF Health
Teoxane
Multiple Myeloma Ireland
In Focus: Up Close with Presbyopia
Scientific Education Support
Answers in CME
Medscape
Eyetube
CME Outfitters, LLC
ReachMD
American Society of Clinical Oncology (ASCO)
University of Colorado Anschutz Medical Campus
Foggy
ReachMD
Answers in CME
Pediatric Dermatology Research Alliance
Takeda
Takeda
Mayo Clinic
JCP
PVI, PeerView Institute for Medical Education
Patrick Hayes
PVI, PeerView Institute for Medical Education
The Derm Consult
Projects In Knowledge, Inc
Research Partnership
Vascular Adviser Team
MediCom Oncology
Medscape
BloodStream Media
Projects In Knowledge, Inc
KIRO Radio 97.3 FM
Multiple Myeloma Research Foundation (MMRF)
touchpodcast
The George Washington University Hospital
Bladder Cancer Advocacy Network
The National Kidney Foundation (NKF) Singapore
Nicole Cooper & Sean Crank
PVI, PeerView Institute for Medical Education
PVI, PeerView Institute for Medical Education
ReachMD
Rajani Katta and Samir Desai
Dr Neil Love
PVI, PeerView Institute for Medical Education
Artcraft Health
Craig Mateer
ReachMD
PVI, PeerView Institute for Medical Education
ReachMD
PeerVoice
MDBriefCase
Jeremy
PeerVoice
PVI, PeerView Institute for Medical Education
PVI, PeerView Institute for Medical Education
Richard Elion, MD
Frank
Physis Foundation
The Patient Voice Initiative
Chronicle Companies
Imaz Athar
LACNETS
Dr. Amanda Selk- OBGYN, President of the NA-ISSVD, Associate Professor
PeerVoice
Leukaemia Care charity
PeerVoice
Medscape
ReachMD
Eyetube
medthority
Scientific Education Support
PVI, PeerView Institute for Medical Education
PeerVoice
PVI, PeerView Institute for Medical Education
Charles Vega, MD
PVI, PeerView Institute for Medical Education
U.S. Food and Drug Administration, Center for Drug Evaluation and Research
Dmitriy Kedrin
National Marrow Donor Program/Be The Match
PVI, PeerView Institute for Medical Education
PeerVoice
Evolve Medical Education, LLC and The Fundingsland Group
Meagan Thomas
Answers in CME
PeerVoice
The Aplastic Anemia and MDS International Foundation
Medscape
Biohaven Pharmaceuticals
@Point of Care